Rebecca A. Alderden, Matthew D. Hall, and Trevor W. Hambley
Centre for Heavy Metals Research, School of Chemistry, The University of Sydney, 2006 NSW, Australia
Cisplatin is currently one of the most widely used anticancer drugs in the world. The unlikely events surrounding the discovery of its anticancer activity, subsequent introduction into the clinic, and the continuing research into platinum compounds is the subject of this review. Cisplatin and related platinum compounds remain the focus of extensive research. Reliable methods for the synthesis of such compounds have been developed and it has been established that they exert their anticancer activity through interaction with DNA. The search continues for a platinum drug to improve upon the clinical performance of cisplatin. Several have entered clinical trials but have been abandoned for a variety of reasons. However, preliminary results on novel compounds have been particularly promising.
More Information
Citation
Alderden, Rebecca A.; Hall, Matthew D.; Hambley, Trevor W. J. Chem. Educ.2006 83 728.
The "Chemistry Teacher Connection" (CTC) is especially for high school chemistry teachers. For only $40/year, it offers an online-only subscription to CLIC along with membership in the Division of Chemical Education, normally $65/year. CTC subscribers receive access to all articles and supplements from 1996 through the current issue.
Through special arrangement with the ACS, JCE High School CLIC is now able to provide subscribers with online access to Chemical & Engineering News articles that have been selected specifically for secondary science instructors and their students.
Occasionally, collections of JCE back issues become available for donation to individual teachers, schools, or libraries. JCE matches collections with interested recipients. Recipients pay shipping costs or pick up the collection.